Lettmann Jason 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Sep 18, 2025
Insider Transaction Report
Form 4
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2025-09-17$1.08/sh+71,163$76,892→ 305,121 total - Purchase
Common Stock
2025-09-16$1.07/sh+21,070$22,461→ 233,958 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.09, inclusive.